News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene Corporation (CELG) Warns UK Docs of Imnovid Birth Defects Risk


10/14/2013 7:05:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Celgene Corp has warned doctors in the UK that its newly approved blood cancer drug Imnovid can cause life-threatening birth defects. In a letter to healthcare professionals, the drugmaker stressed that the medicine is structurally related to thalidomide, a known human teratogen that causes severe life-threatening birth defects. Because of a similar effect observed in rabbits and rats, taking Imnovid (pomalidomide) during pregnancy is also expected to have a tetratogenic effect in humans, it said.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES